Skip to main content
Clinical Trials/NCT01206790
NCT01206790
Completed
Not Applicable

Immunological Changes Through Narrative Treatment of PTSD in Torture Victims

University of Konstanz1 site in 1 country47 target enrollmentJune 2009
ConditionsPTSD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PTSD
Sponsor
University of Konstanz
Enrollment
47
Locations
1
Primary Endpoint
PTSD diagnosis and severity score according to the Clinicians Administered PTSD Scale (CAPS)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Posttraumatic stress disorder (PTSD) is associated with poor health, high health care utilization, and an increased risk for a variety of somatic, inflammatory and autoimmune diseases. Research, including our own findings, indicates immunological alterations in PTSD patients. The aim of this study is to investigate whether alterations in the immune system of PTSD patients are reversible through a trauma-specific short-term therapy (Narrative Exposure Therapy).

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
January 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Konstanz
Responsible Party
Principal Investigator
Principal Investigator

Iris-Tatjana Kolassa

Prof. Dr. Iris-Tatjana Kolassa

University of Ulm

Eligibility Criteria

Inclusion Criteria

  • PTSD diagnosis
  • experiences of organized violence/torture

Exclusion Criteria

  • psychotic disorder
  • chronic inflammatory diseases

Outcomes

Primary Outcomes

PTSD diagnosis and severity score according to the Clinicians Administered PTSD Scale (CAPS)

Time Frame: 4 month after completion of treatment

Secondary Outcomes

  • changes in immunological parameters(4 months after completion of treatment)

Study Sites (1)

Loading locations...

Similar Trials